Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 9761919, 8 pages
https://doi.org/10.1155/2018/9761919
Research Article

MUC1 and MUC5AC Acting on Helicobacter pylori-Related Deficiency and Solid Syndrome of Spleen and Stomach

1Institute of Gastroenterology, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
2Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400037, China
3The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, China

Correspondence should be addressed to Ling Hu; moc.931@nc.lh

Received 8 February 2018; Accepted 14 March 2018; Published 23 April 2018

Academic Editor: Victor Kuete

Copyright © 2018 Ling Hu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Suerbaum and P. Michetti, “Helicobacter pylori infection,” The New England Journal of Medicine, vol. 347, no. 15, pp. 1175–1186, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Parsonnet, G. D. Friedman, D. P. Vandersteen et al., “Helicobacter pylori infection and the risk of gastric carcinoma,” The New England Journal of Medicine, vol. 325, no. 16, pp. 1127–1131, 1991. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Yakirevich and M. B. Resnick, “Pathology of gastric cancer and its precursor lesions,” Gastroenterology Clinics of North America, vol. 42, no. 2, pp. 261–284, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. D. E. Kirschner and M. J. Blaser, “The dynamics of Helicobacter pylori infection of the human stomach,” Journal of Theoretical Biology, vol. 176, no. 2, pp. 281–290, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Blaser, “Ecology of Helicobacter pylori in the human stomach,” The Journal of Clinical Investigation, vol. 100, no. 4, pp. 759–762, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. C. He, H. Tu, L. Sun et al., “Helicobacter pylori-related host gene polymorphisms associated with susceptibility of gastric carcinogenesis: A two-stage case-control study in Chinese,” Carcinogenesis, vol. 34, no. 7, pp. 1450–1457, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Marín, C. Bonet, X. Muñoz et al., “Genetic variation in MUC1, MUC2 and MUC6 genes and evolution of gastric cancer precursor lesions in a long-term follow-up in a high-risk area in Spain,” Carcinogenesis, vol. 33, no. 5, pp. 1072–1080, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Rashid, A. S. Teixeira, U. Qureshi, S. P. Pereira, M. R. Novelli, and D. M. Swallow, “Apical MUC1 expression revealed on the foveolar epithelium in H. pylori gastritis,” British Journal of Cancer, vol. 108, no. 5, pp. 1113–1118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. McGuckin, A. L. Every, C. D. Skene et al., “Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis,” Gastroenterology, vol. 133, no. 4, pp. 1210–1218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Zhang, H. Zhang, L. Yu, and Y. Cao, “Helicobacter pylori Dwelling on the Apical Surface of Gastrointestinal Epithelium Damages the Mucosal Barrier Through Direct Contact,” Helicobacter, vol. 19, no. 5, pp. 330–342, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. S. K. Lindén, Y. H. Sheng, A. L. Every et al., “MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy,” PLoS Pathogens, vol. 5, no. 10, article e1000617, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Boltin, R. Gingold-Belfer, R. Dickman et al., “Gastric mucin expression in first-degree relatives of gastric cancer patients,” European Journal of Gastroenterology & Hepatology, vol. 26, no. 7, pp. 710–714, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. D. W. Kufe, “Mucins in cancer: function, prognosis and therapy,” Nature Reviews Cancer, vol. 9, no. 12, pp. 874–885, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Kocer, M. Ulas, Y. Ustundag et al., “A confirmatory report for the close interaction of Helicobacter pylori with gastric epithelial MUC5AC expression,” Journal of Clinical Gastroenterology, vol. 38, no. 6, pp. 496–502, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. E. Baldus, S. P. Mönig, V. Arkenau et al., “Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric carcinoma,” Annals of Surgical Oncology, vol. 9, no. 9, pp. 887–893, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Wang and A. Xu, “Zheng: a systems biology approach to diagnosis and treatments,” Science, vol. 346, no. 6216, pp. S13–S15, 2014. View at Google Scholar
  17. J. van der Greef, “Perspective: all systems go,” Nature, vol. 480, no. 7378, article S87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. G. H. Lv and S. X. Lao, “Establishement and evaluation for the animal model of damp-heat of spleen-stomach syndrome,” Journal of Guangzhou University of Traditional Chinese Medicine, no. 03, pp. 231–235, 2005. View at Google Scholar
  19. F. S. Zhou and L. N. Zhao, “Research on the establishment for the diagnostic standards of spleen-qi deficiency in chronic subepithelial gastritis,” Zhong Yi Yao Xue Kan, no. 12, pp. 2178-2179, 2006. View at Google Scholar
  20. W. W. Chen, Y. F. Wang, S. X. Lao et al., “Profile of gene differential expression in chronic gatritis with deficiency of spleen-qi patients,” Zhong Guo Bing Li Sheng Li Za Zhi, no. 01, pp. 148–152, 2008. View at Google Scholar
  21. J. K. Liang, L. Hu, X. F. Zheng, X. H. Yan, and W. L. Gu, “Study of Th1/Th2 balance on peripheral blood of chronic gastritis patients with pi-wei damp-heat syndrome,” Zhong Guo Zhong Xi Yi Jie He Za Zhi, no. 03, pp. 322–324+328, 2012. View at Google Scholar
  22. P. Malfertheiner, F. K. Chan, and K. E. McColl, “Peptic ulcer disease,” The Lancet, vol. 374, no. 9699, pp. 1449–1461, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Y. Fang, W. Z. Liu, Y. Shi, Z. Z. Ge, and S. D. Xiao, “Consensus on chronic gastritis in China - second national consensus meeting on chronic gastritis (14–16 september 2006 Shanghai, China),” Journal of Digestive Diseases, vol. 8, no. 2, pp. 107–119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Ricci, J. Holton, and D. Vaira, “Diagnosis of Helicobacter pylori: invasive and non-invasive tests,” Best Practice & Research Clinical Gastroenterology, vol. 21, no. 2, pp. 299–313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. C.-A. Tseng, W.-M. Wang, and D.-C. Wu, “Comparison of the clinical feasibility of three rapid urease tests in the diagnosis of Helicobacter pylori infection,” Digestive Diseases and Sciences, vol. 50, no. 3, pp. 449–452, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Bermejo, D. Boixeda, J. P. Gisbert et al., “Rapid urease test utility for Helicobacter pylori infection diagnosis in gastric ulcer disease,” Hepatogastroenterology, vol. 49, no. 44, pp. 572–575, 2002. View at Google Scholar · View at Scopus
  27. X. Y. Zheng, Guidelines for the Research of New Clinical Drugs of Chinese Medicine (Trial Implementation), China Medical Science Press, Beijing, China, 2002.
  28. L. Hu, N. J. Cui, Q. Luo, Z. Zhou, and S. X. Lao, “HSP70 and NF-κB mediating damp-heat syndrome of spleen and stomach of chronic gastritis,” Journal of Guangzhou University of Traditional Chinese Medicine, no. 06, pp. 587–591+669-670, 2010. View at Google Scholar
  29. M. F. Dixon, R. M. Genta, J. H. Yardley, and P. Correa, “Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994,” The American Journal of Surgical Pathology, vol. 20, no. 10, pp. 1161–1181, 1996. View at Google Scholar
  30. L. Z. Xu and W. T. Yang, “The diagnostic standards for the results of immunohistochemistry,” China Oncology, no. 04, pp. 229–231, 1996. View at Google Scholar
  31. T. Zhao, M. G. Zhu, Z. Y. Huang, Y. L. Zhang, S. J. Zhang, and M. F. Li, “Contrastive analysis for the synchronization test of lung cancer gene protein product,” Ai Zheng, no. 01, pp. 13–15, 1995. View at Google Scholar
  32. J. van der Greef, H. van Wietmarschen, J. Schroën, M. Wang, T. Hankemeier, and G. Xu, “Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine,” Planta Medica, vol. 76, no. 17, pp. 2036–2047, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Li, T. Ma, J. Gu, X. Liang, and S. Li, “Imbalanced network biomarkers for traditional Chinese medicine syndrome in gastritis patients,” Scientific Reports, vol. 3, article 1543, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. J. Zheng, “Exploration of microcosmic Chinese medicine used by western medicine,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 35, no. 2, pp. 133–136, 2015. View at Google Scholar
  35. L. Hu, G. L. Chen, and W. W. Chen, “The application of spleen deficiency theory: the topic serie of inheritant and application spleen and stomach theory (4),” Journal of Traditional Chinese Medicine, no. 14, pp. 1174–1177, 2012. View at Google Scholar
  36. “Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994,” IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 61, pp. 1–241, 1994.
  37. J. H. B. Van de Bovenkamp, J. Mahdavi, A. M. Korteland-Van Male et al., “The MUC5AC glycoprotein is the primary receptor for Helicobacter pylori in the human stomach,” Helicobacter, vol. 8, no. 5, pp. 521–532, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. J. B. E. Benjamin, V. Jayanthi, and H. Devaraj, “MUC1 expression and its association with other aetiological factors and localization to mitochondria in preneoplastic and neoplastic gastric tissues,” Clinica Chimica Acta, vol. 411, no. 23-24, pp. 2067–2072, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Sachs and D. R. Scott, “Helicobacter pylori: Eradication or preservation,” F1000 Medicine Reports, vol. 4, no. 1, article no. 7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. J. S. Park, J.-S. Yeom, J.-H. Seo et al., “Immunohistochemical Expressions of MUC2, MUC5AC, and MUC6 in Normal, Helicobacter pylori Infected and Metaplastic Gastric Mucosa of Children and Adolescents,” Helicobacter, vol. 20, no. 4, pp. 260–268, 2015. View at Publisher · View at Google Scholar · View at Scopus